Inhibition of the glucocorticoid receptor expression by diverse tumor promoters in SENCAR mouse epidermis

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 241-246

  Kang, Ho Il ^a   Budunova, Irina V ^a   Carbajal, Steve ^a   Slaga, Thomas J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

glucocorticoid receptor; mouse epidermis; tumor promoter

Indexed keywords

BENZOYL PEROXIDE; CHRYSAROBIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; OKADAIC ACID; PHORBOL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; EPIDERMIS; GENE EXPRESSION; HYPERPLASIA; ISOTOPE LABELING; KERATINOCYTE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR BINDING; SKIN CANCER;

EID: 0031049801     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.2.241     Document Type: Article

References (38)

1. Slaga TJ, Budunova IV, Gimenez-Conti IB and Aldaz CM: Mouse skin carcinogenesis model. J Invest Dermatol Symp Proc 1: 151-156, 1996.
2. Schwartz JA, Viaje A, Slaga TJ, Yuspa SH, Hennings H and Lihta U: Fluocinolone acetonide: a potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem Biol Interac 17: 331-347, 1977.
3. Slaga TJ: Can tumor promotion be effectively inhibited? In: Models, Mechanisms and Etiology of Tumor Promotion. Börzönyi M, Day NE and Lapis K (eds).Vol 56. IARC Scientific Publications, Lyon, France, pp497-509, 1984.
4. DiGiovanni J, Kruszcwski FH and Chenicek KJ: Modulation of chrysarobin skin tumor promotion. Carcinogenesis 9: 1445-1450, 1988.
5. Verma AK, Garcia CT, Ashendel CL and Boutwell RK: Inhibition of 7-brommethyl-benzanthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Cancer Res 43: 3045-3049, 1983.
6. Trainin N: Adrenal imbalances in mouse skin carcinogenesis. Cancer Res 23: 415-419, 1963.
7. Ponce M: Glucocorticoid receptors. Curr Prob Dermatol 21: 20-28, 1993.
8. Beato M, Herrlich P and Schultz G Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857, 1995.
9. Okret S, Dong Y, Bronnegard M and Gustafsson JA: Regulation of glucocorticoid receptor expression. Biochemie 73: 51-59, 1991.
10. Oakley RH and Cidlowski JA: Homologous down-regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eucariotic Gene Exp 3: 63-88, 1993.
11. Peiffer A, Lapointe B and Barden N: Horomonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain. Endocrinology 129: 2166-2174, 1991.
12. Budunova IV, Carbajal S, Kang H-I, Viaje A and Slaga TJ: Glucocorticoid receptor expression and function are altered during mouse skin carcinogenesis. Molec Carcinog (In press).
13. Davidson KA and Slaga TJ: Effect of phorbol ester tumor promoters and hyperplasiogenic agents on cytoplasmic glucocorticoid receptors in epidermis. J Invest. Dermatol 79: 378-382, 1982.
14. Davidson KA and Slaga TJ: Glucocorticoid receptor levels in mouse skin after repetitive applications of 12-O-tetradecanoyl-phorbol-13-acetate and mezerein. Cancer Res 43: 3847-3851, 1983.
15. Castagna M, Takai Y, Kaibuchi K, Sano U, Kikkawa U and Nishizuka Y: Direct activation of calcium activated phospholipid-dependent protein kinasc by tumor promoting phorbol esters. J Biol Chem 257: 7847-7851, 1982.
16. Suganuma M, Fujiki H, Sugari H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K and Sugimura T: Okadaic acid: an additional non-phorbol-12-tctradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85: 1768-1771, 1988.
17. Honkanen RE, Codispoti BA, Tse K and Boynton AL: Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatase. Toxicon 32: 339-350, 1994.
18. Slaga TJ: Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical generating compound. Science 213: 1023-1025, 1981.
19. Battalora MS and Johnston DA: The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice. Cancer Lett 98: 19-25, 1995.
20. Battalora MS, Kruszewski FH and DiGiovanni J: Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants. Carcinogenesis 14: 2507-2512, 1993.
21. Klein-Szanto AJP and Slaga TJ: Effects of peroxides on rodent skin: epidermal hyperplasia and tumor promotion. J Invest Dermatol 79: 30-34, 1982.
22. Klein-Szanto AJP: Morphological evaluation of tumor promoter effects on mammalian skin. In: Mechanisms of Tumor Promotion. Tumor Promotion and Skin Carcinogenesis. Slaga TJ (ed).Vol II. CRC Press, Boca Raton, FL, pp42-73, 1984.
23. Kruszewski FH, Naito M, Naito Y and DiGiovanni J: Histologic alterations produced by chrysarobin (I,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity. J Invest Dermatol 93: 64-71, 1989.
24. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
25. Balmain A, Krumlauf R, Vas JK and Birnie GD: Cloning and characteristic of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res 10: 4259-4277, 1982.
26. Scatchard G: The attraction of proteins for small molecules. Ann NY Acad Sci 51: 660-672, 1949.
27. Oakley RH, Sar M and Cidlowski JA: The human glucocorticoid receptor β isoform. J Biol Chem 271: 9550-9559, 1996.
28. Faisst S and Meyer S: Compilation of vertebrate-encoded transcriptional factors. Nucleic Acids Res 20: 3-26, 1992.
29. Karin M: Signal transduction from cell surface to nucleus in development and disease. FASEB J 6: 2581-2590, 1992.
30. Zong J, Ashraf J and Thompson EB: The promoter and first untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites. Mol Cell Biol 10: 5580-5589, 1990.
31. LeClerc S, Palaniswani R, Xie B and Govindan MV: Molecular cloning and characterization of a factor that binds the human glucocorticoid receptor gene and represses its expression. J Biol Chem 266: 17333-17340, 1991.
32. Barrett TJ, Vig E and Vedeckis WV: Coordinate regulation of glucocorticoid receptor and c-jnn mRNA levels: evidence for cross-talk between two signaling pathways at the transcriptional level. Mol Endocrinol 8: 1336-1346, 1994.
33. Moudgil VK: Phosphorylation of steroid hormone receptors. Biochim Biophys Acta 1055: 243-258, 1990.
34. Orti E, Bodwell JE and Munk C: Phosphorylation of steroid hormone receptors. Endocrinol Rev 13: 105-128, 1992.
35. Troll W, Belman S, Weisner R and Shellabarger CJ: Protease action in carcinogenesis. In: Biological Function of Proteases. Holzer H and Tschesche H (eds). Springer, New York, pp165-170, 1979.
36. Yang-Yen H-F, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J and Karin M: Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215, 1990.
37. Lee KS, Favre B, Hemmings BA, Kiefer B and Nagamine Y: Okadaic acid-dependent induction of the urokinase-type plasminogen activator gene associated with stabilization and autoregulation of c-Jun. J Biol Chem 269: 2887-2894, 1994.
38. Rieckmann P, Thevenin C and Kehrl JH: Okadaic acid is a potent inducer of AP-1, NF-kappaB and tumor necrosis factor alpha in human B lymphocytes. Biochem Biophys Res Commun 187:51-57, 1992.